Arthritis, Rheumatoid: all 2,963 studies
Page 17 of 30. Open to participants first (394), then studies with results posted, then the rest; newest registration first within each.
- CXCL10 As a Biomarker Of ILD in Patients WithRAStatus unknownNCT04356066Not applicable
- Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 OutbreakCompletedNCT04351399
- Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET)Status unknownNCT04350216Phase 4
- IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORTCompletedNCT04347798
- Vitamin D as a Key Player in Rheumatoid ArthritisCompletedNCT04344405Phase 3
- Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid ArthritisCompletedNCT04343378
- Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ TabletsCompletedNCT04340115
- A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid ArthritisCompletedNCT04333771Phase 3
- Effects of Achieving SDAI Remission on Joint Space Outcomes Progression in Early Rheumatoid Arthritis: an HR-pQCT StudyActive, not recruitingNCT04324892
- Promoting Engagement in Physical Activity in Early Rheumatoid Arthritis: Proof of Concept StudyCompletedNCT04321798Not applicable
- Information and Acceptability of BiosimilarsStatus unknownNCT04321291Not applicable
- The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid ArthritisStatus unknownNCT04315818
- A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTXStatus unknownNCT04312815Phase 3
- Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung DiseaseTerminatedNCT04311567Phase 4
- Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid PopulationsTerminatedNCT04309227Not applicable
- Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudySuspendedNCT04306939
- The RA PROTECTION StudyCompletedNCT04306744Not applicable
- MySlainte: Testing the Effect of Involving Partners in a CVD Prevention Community Lifestyle ProgramStatus unknownNCT04300465Not applicable
- The Clinical Feasibilityof a Multi-modal Photoacoustic/Ultrasonic Imaging System in Rheumatoid ArthritisStatus unknownNCT04297475
- Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDsCompletedNCT04286789Phase 1
- Lysophosphatidic Acid / Autotaxin Axis in Rheumatoid Lung DiseaseStatus unknownNCT04284735Not applicable
- Biomarkers in Rheumatoid Arthritis Treated With Anti-interleukin-6 TherapyStatus unknownNCT04281602
- Prolactin Hormone in Rheumatoid Arthritis Patients With PeriodontitisStatus unknownNCT04279691
- Sleep Quality in Patients With Rheumatoid ArthritisCompletedNCT04278170
- The Anti-inflammatory Effects of Harkány Medicinal WaterStatus unknownNCT04275206Not applicable
- An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid ArthritisCompletedNCT04267536
- Evaluating the Role of Intra-articular Injections of Platelet Rich Plasma (PRP) in Patients With Rheumatoid Arthritis.Status unknownNCT04264494Not applicable
- Effectiveness of an Exercise Program and Education Through a Mobile Application for the Management of Patients With Hand Osteoarthritis and Rheumatoid ArthritisCompletedNCT04263974Not applicable
- A MEDiterranean Diet in Rheumatoid ArthritisCompletedNCT04262505Not applicable
- Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)CompletedNCT04255134Phase 4
- Effects of Acute Exercise on BDNF Levels in Rheumatoid Arthritis PatientsStatus unknownNCT04254146Not applicable
- Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab TreatmentActive, not recruitingNCT04251741Phase 4
- Postprandial Inflammation in Rheumatoid ArthritisCompletedNCT04247009Not applicable
- Rheumatoid Arthritis Coping EnhancementCompletedNCT04246827Not applicable
- Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2Active, not recruitingNCT04227535
- Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid ArthritisCompletedNCT04227366Phase 3
- MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle BiomechanicsCompletedNCT04226131Not applicable
- Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease ActivityCompletedNCT04222920Phase 4
- A Pilot Study to Explore the Role of Gut Flora in Rheumatoid ArthritisWithdrawnNCT04210817
- A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT04204603Phase 2
- Serum Calprotectin Level in Patients With Rheumatoid Arthritis and OsteoarthritisStatus unknownNCT04201886Phase 4
- Identification of Novel Molecular Targets for Rheumatoid Arthritis PatientsStatus unknownNCT04201535
- Methotrexate and Metformin in Rheumatoid Arthritis PatientsCompletedNCT04196868Phase 2
- Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung UltrasoundCompletedNCT04195789
- A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving MethotrexateCompletedNCT04192617Phase 2
- Effectiveness and Adherence of Golimumab in Rheumatoid ArthritisStatus unknownNCT04188249
- A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis PatientsStatus unknownNCT04179513Phase 1
- Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for InjectionStatus unknownNCT04178850Phase 3
- Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy SubjectsStatus unknownNCT04178070Phase 1
- Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid ArthritisCompletedNCT04177173Phase 4
- Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT ProjectCompletedNCT04175886
- Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid ArthritisCompletedNCT04170504Phase 2/3
- Tocilizumab REMission in Early RACompletedNCT04157010Phase 4
- Prediction Medical Device for Rheumatoid Arthritis (PREDIRA)Status unknownNCT04147026Not applicable
- Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid ArthritisCompletedNCT04144101Phase 4
- Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDsStatus unknownNCT04139954
- Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid ArthritisStatus unknownNCT04136262Phase 2/3
- Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease ProgressionActive, not recruitingNCT04136223
- Nerve Block of the Proximal Interphalangeal Joints PIPs in Rheumatoid Arthritis (RA) Patients: a Prospective Pilot StudyCompletedNCT04130178Not applicable
- TOLERA: Tolerance Enhancement in RAStatus unknownNCT04120831Phase 2
- Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid ArthritisWithdrawnNCT04117165Not applicable
- A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving TocilizumabStatus unknownNCT04115423
- Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory ArthritisWithdrawnNCT04115020Phase 2
- Role of CTHRC1 in Diagnosis of Rheumatoid ArthritisStatus unknownNCT04092244
- A Real-world Study of Imraldi® UseCompletedNCT04089514
- CTHRC1 Abiomarker in Rheumatoid Arthritis DiagnosisStatus unknownNCT04085471
- JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis)TerminatedNCT04084223Not applicable
- Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and EnbrelStatus unknownNCT04079374Phase 3
- An Extension Study of TS-152 in Subjects with Rheumatoid ArthritisCompletedNCT04077567Phase 3
- The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis PatientsCompletedNCT04068246Phase 1/2
- Optimal MTX Dose With Folic Acid Randomized Case-control TrialStatus unknownNCT04066803Phase 4
- Study of the Articular Microbiota in Rheumatoid Arthritis.CompletedNCT04056234
- Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.CompletedNCT04056039Phase 2
- Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT04049448Phase 2
- Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateCompletedNCT04038970Phase 2
- Adipokines as Predictors of Foot Function, Pain, and Disability in Patients With Rheumatoid ArthritisCompletedNCT04036669
- Effectiveness of Multigrain Supplementation Among the Rheumatoid Arthritis PatientsCompletedNCT04033809Not applicable
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
- Assessment of Leflunomide Efficacy and Hepatotoxicity in Patients With Rheumatoid Arthritis Through Pharmacokinetic and Genetic ApproachesCompletedNCT04022525
- Factors of ILD in Newly Diagnosed Rheumatoid ArthritisStatus unknownNCT04002765Not applicable
- 14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid ArthritisCompletedNCT03999528
- ESTIMATION OF GINGIVAL CREVICULAR LEVEL OF YKL40Status unknownNCT03995615Not applicable
- KickStart30: A 30-Day Intervention for Patients With Rheumatoid Arthritis (RA)CompletedNCT03993548Not applicable
- Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBaseStatus unknownNCT03980639
- Interstitial Lung Disease in Early Rheumatoid ArthritisStatus unknownNCT03977415
- Uromodulin in Rheumatoid ArthritisCompletedNCT03972098
- Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid ArthritisCompletedNCT03971253
- Cardiovascular Profiles in Rheumatoid ArthritisCompletedNCT03960515
- CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic ArthritisCompletedNCT03953378
- Quality of Life Related to Health in Spa UsersStatus unknownNCT03952897
- Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Rheumatoid Arthritis Refractory to MethotrexateStatus unknownNCT03944096Phase 2
- Compare Diagnostic Performance of DIXON &CHESS Sequences Calculating RAMRIS Score in Early Rheumatoid Arthritis.CompletedNCT03943563Not applicable
- WORKWELL: Testing Work Advice for People With ArthritisCompletedNCT03942783Not applicable
- Objective Measurement Methods for Autoimmune Disease and Dry Eye SyndromeWithdrawnNCT03937271
- Methotrexate Use Improvement in Rheumatoid Arthritis Using Biomarker FeedbackCompletedNCT03913728Not applicable
- Aerobic Exercise Program Followed by Cold Water Immersion: Effects on Arthritis Patients Arterial StiffnessCompletedNCT03911830Not applicable
- Bloodstream Infections in Patients With Rheumatoid ArthritisCompletedNCT03908086
- A Multiple Dose of HL237 in Healthy Male SubjectStatus unknownNCT03896594Phase 1
- Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704ACompletedNCT03890302Phase 1
- Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy VolunteersCompletedNCT03868072Phase 1